PillRx only · Injection, Solution, Concentrate · Intravenous
Docetaxel
Docetaxel
7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
7 active makers
7 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
912
Rx · 2026 Q1
5.6K
Units dispensed
-50%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it7 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Accord Healthcare Inc. | unknown | 3 | SUPPLYING |
| Sanofi-Aventis U.S. LLC | unknown | 3 | SUPPLYING |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | unknown | 3 | SUPPLYING |
| Meitheal Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| Actavis Pharma, Inc. | unknown | 2 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 2 | SUPPLYING |
| Mylan Institutional LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 27, 2018RECALLRecall (Class II): Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., ND…
Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed. — Recalling firm: Sanofi-Aventis U.S. LLC — US nationwide